These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 16143410)
1. The effect of Delta9-tetrahydrocannabinol on sensorimotor gating in socially isolated rats. Malone DT; Taylor DA Behav Brain Res; 2006 Jan; 166(1):101-9. PubMed ID: 16143410 [TBL] [Abstract][Full Text] [Related]
2. Antipsychotics improve Delta9-tetrahydrocannabinol-induced impairment of the prepulse inhibition of the startle reflex in mice. Nagai H; Egashira N; Sano K; Ogata A; Mizuki A; Mishima K; Iwasaki K; Shoyama Y; Nishimura R; Fujiwara M Pharmacol Biochem Behav; 2006 Jun; 84(2):330-6. PubMed ID: 16820196 [TBL] [Abstract][Full Text] [Related]
3. Repeated but not acute treatment with ∆⁹-tetrahydrocannabinol disrupts prepulse inhibition of the acoustic startle: reversal by the dopamine D₂/₃ receptor antagonist haloperidol. Tournier BB; Ginovart N Eur Neuropsychopharmacol; 2014 Aug; 24(8):1415-23. PubMed ID: 24846537 [TBL] [Abstract][Full Text] [Related]
4. Effects of cannabinoid receptor ligands on psychosis-relevant behavior models in the rat. Martin RS; Secchi RL; Sung E; Lemaire M; Bonhaus DW; Hedley LR; Lowe DA Psychopharmacology (Berl); 2003 Jan; 165(2):128-35. PubMed ID: 12404071 [TBL] [Abstract][Full Text] [Related]
5. The 5-HT1A receptor agonist MKC-242 reverses isolation rearing-induced deficits of prepulse inhibition in mice. Sakaue M; Ago Y; Baba A; Matsuda T Psychopharmacology (Berl); 2003 Oct; 170(1):73-9. PubMed ID: 12768276 [TBL] [Abstract][Full Text] [Related]
6. Cannabinoid receptor antagonists counteract sensorimotor gating deficits in the phencyclidine model of psychosis. Ballmaier M; Bortolato M; Rizzetti C; Zoli M; Gessa G; Heinz A; Spano P Neuropsychopharmacology; 2007 Oct; 32(10):2098-107. PubMed ID: 17299506 [TBL] [Abstract][Full Text] [Related]
7. The effect of SR 141716 and apomorphine on sensorimotor gating in Swiss mice. Malone DT; Long LE; Taylor DA Pharmacol Biochem Behav; 2004 Apr; 77(4):839-45. PubMed ID: 15099930 [TBL] [Abstract][Full Text] [Related]
8. Effects of the cannabinoid CB1 receptor antagonist SR141716A on the behavior of pigeons and rats. Mansbach RS; Rovetti CC; Winston EN; Lowe JA Psychopharmacology (Berl); 1996 Apr; 124(4):315-22. PubMed ID: 8739546 [TBL] [Abstract][Full Text] [Related]
9. Chronic blockade of CB(1) receptors reverses startle gating deficits and associated neurochemical alterations in rats reared in isolation. Zamberletti E; Piscitelli F; Cadeddu F; Rubino T; Fratta W; Fadda P; Di Marzo V; Parolaro D Br J Pharmacol; 2012 Dec; 167(8):1652-64. PubMed ID: 22762735 [TBL] [Abstract][Full Text] [Related]
11. Adolescent exposure to Δ9-tetrahydrocannabinol delays acquisition of paired-associates learning in adulthood. Abela AR; Rahbarnia A; Wood S; Lê AD; Fletcher PJ Psychopharmacology (Berl); 2019 Jun; 236(6):1875-1886. PubMed ID: 30694374 [TBL] [Abstract][Full Text] [Related]
12. Different pharmaceutical preparations of Δ Rohleder C; Pahlisch F; Graf R; Endepols H; Leweke FM Addict Biol; 2020 May; 25(3):e12745. PubMed ID: 30938471 [TBL] [Abstract][Full Text] [Related]
13. HIV Transgenic Rats Demonstrate Impaired Sensorimotor Gating But Are Insensitive to Cannabinoid (Δ9-Tetrahydrocannabinol)-Induced Deficits. Roberts BZ; Minassian A; Halberstadt AL; He YV; Chatha M; Geyer MA; Grant I; Young JW Int J Neuropsychopharmacol; 2021 Nov; 24(11):894-906. PubMed ID: 34338765 [TBL] [Abstract][Full Text] [Related]
14. Discriminative stimulus effects of the cannabinoid antagonist, SR 141716A, in delta -sup-9-tetrahydrocannabinol-treated rhesus monkeys. McMahon LR; France CP Exp Clin Psychopharmacol; 2003 Nov; 11(4):286-93. PubMed ID: 14599262 [TBL] [Abstract][Full Text] [Related]
15. Delta9-THC induced hyperphagia and tolerance assessment: interactions between the CB1 receptor agonist delta9-THC and the CB1 receptor antagonist SR-141716 (rimonabant) in rats. Järbe TU; DiPatrizio NV Behav Pharmacol; 2005 Sep; 16(5-6):373-80. PubMed ID: 16148441 [TBL] [Abstract][Full Text] [Related]
16. Biphasic effects of Δ9-tetrahydrocannabinol on brain stimulation reward and motor activity. Katsidoni V; Kastellakis A; Panagis G Int J Neuropsychopharmacol; 2013 Nov; 16(10):2273-84. PubMed ID: 23830148 [TBL] [Abstract][Full Text] [Related]
17. Iloperidone reduces sensorimotor gating deficits in pharmacological models, but not a developmental model, of disrupted prepulse inhibition in rats. Barr AM; Powell SB; Markou A; Geyer MA Neuropharmacology; 2006 Sep; 51(3):457-65. PubMed ID: 16762376 [TBL] [Abstract][Full Text] [Related]
18. Reversal of isolation rearing-induced deficits in prepulse inhibition by Seroquel and olanzapine. Bakshi VP; Swerdlow NR; Braff DL; Geyer MA Biol Psychiatry; 1998 Mar; 43(6):436-45. PubMed ID: 9532349 [TBL] [Abstract][Full Text] [Related]
19. A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice. Long LE; Chesworth R; Huang XF; McGregor IS; Arnold JC; Karl T Int J Neuropsychopharmacol; 2010 Aug; 13(7):861-76. PubMed ID: 19785914 [TBL] [Abstract][Full Text] [Related]
20. Effects of REM sleep deprivation on sensorimotor gating and startle habituation in rats: role of social isolation in early development. Chang HA; Liu YP; Tung CS; Chang CC; Tzeng NS; Huang SY Neurosci Lett; 2014 Jul; 575():63-7. PubMed ID: 24861517 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]